Brii Biosciences
North America, North Carolina, United States, Durham
Description
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
Investor Profile
Brii Biosciences has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series A (67%)
- Post Ipo Equity (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Clinical Trials
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
